Table 2. Summary of the cohort-based studies included in the analysis.
Author | Date | Place | Race | Mean age at diagnosis | Design | Cohort |
Brandt6 | 1961–2006 | Sweden | Caucasian | NA, aged younger than 75 | Cohort study | 3,900,000 men from the Swedish cancer registry |
Cerhan78 | 1987–1995 | USA, Iowa | Caucasian | 73,6 A | Prospective cohort study | 1557 population-based controls from case-control study in Iowa from 1987–1989 |
Chen49 | 1990–2004 | USA | Caucasian | NA | Prospective cohort study B | 43494 men from the Health Professionals Follow-Up Study cohort |
Kalish79 | 1987–1997 | USA, Boston area | Caucasian | 65,2 A | Retrospective cohort study | 1149 men from the Massachusetts Male Aging Cohort |
Kerber7 | 1966–2000 | USA, Utah | Caucasian | NA | Nested case-control, density samping | 11572 cases and 11572 controlsfrom the Utah Population Database |
Park80 | 1993–2006 | USA, California | Mixed | NA | Nested case-control, cumulative sampling | 729 cases and 729 controls from the Multiethnic Cohort |
Schuurman81 | 1986–1992 | The Netherlands | Caucasian | 64,2 A | Prospective cohort study | 52879 men from the Municipal population registries |
Sun82 | 1992–2006 | USA | Caucasian | NA | Nested case-control, density sampling | 1157 cases and 1157 controls from the Prostate Lung and Ovarian Cancer Screening Trial cohort |
Calculated from the reported distribution of age of the cases at diagnosis.
Data on exposure to family history was available at baseline, however the updated data from 1996 was used in the analysis.